Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 3/20 | 0.33 |
| ▸ | PLAU | P00749 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31079619 | 1.00 | SIGMAR1 (0.39) | SIGMAR1CA2CA1HTR6ANPEP | |
| SCHEMBL29090034 | 0.81 | ALDH1A1 (0.37) | CA2CA1USP2ALDH1A1GAA | |
| SCHEMBL6721448 | 0.72 | SIGMAR1 (0.43) | SIGMAR1ANPEPPLAUIDO1 | |
| SCHEMBL30779196 | 0.71 | CA2 (0.40) | SIGMAR1CA2CA1HTR6ANPEP | |
| SCHEMBL10780065 | 0.71 | SIGMAR1 (0.42) | SIGMAR1PLAUIDO1 | |
| SCHEMBL6676676 | 0.71 | PLAU (0.45) | SIGMAR1ANPEPPLAUIDO1 | |
| SCHEMBL5255259 | 0.71 | PLAU (0.45) | SIGMAR1ANPEPPLAUIDO1 | |
| SCHEMBL15547683 | 0.71 | SIGMAR1 (0.42) | SIGMAR1ANPEPPLAUIDO1 | |
| SCHEMBL30724832 | 0.71 | SIGMAR1 (0.42) | SIGMAR1PLAUIDO1 | |
| SCHEMBL30160918 | 0.70 | SIGMAR1 (0.39) | SIGMAR1CA2CA1ANPEPPLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2149 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150203496-A1 | ALIPHATIC SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2015-07-23 | — | — | US | claimed |
| US-20150111914-A1 | SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2015-04-23 | — | — | US | claimed |
| US-20150087641-A1 | HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. | 2015-03-26 | — | — | US | claimed |
| US-20150080440-A1 | EPOTHILONE DERIVATIVES | R-PHARM US OPERATING LLC | 2015-03-19 | — | — | US | claimed |
| EP-2846799-A1 | SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2015-03-18 | — | — | EP | claimed |
| EP-2846800-A1 | HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2015-03-18 | — | — | EP | claimed |
| EP-2846798-A2 | ALIPHATIC SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2015-03-18 | — | — | EP | claimed |
| EP-2340025-B1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2014-10-15 | — | — | EP | claimed |
| US-8765759-B2 | Monocyclic CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2014-07-01 | — | — | US | claimed |
| EP-2339919-B1 | BICYCLIC DIHYDROIMIDAZOLONE CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2014-03-12 | — | — | EP | claimed |
| JP-2006520381-A | — | — | 2006-09-07 | — | — | JP | claimed |
| JP-2006520388-A | — | — | 2006-09-07 | — | — | JP | claimed |
| US-20060189593-A1 | Aryl spirohydantoin cgrp receptor antagonists | MERCK SHARP & DOHME LLC | 2006-08-24 | — | — | US | claimed |
| WO-2006031606-A2 | CARBOXAMIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2006-03-23 | — | — | WO | claimed |
| WO-2006031513-A2 | ARYL SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2006-03-23 | — | — | WO | claimed |
| EP-1613368-A2 | CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS | Merck & Co. Inc. (US) | 2006-01-11 | — | — | EP | claimed |
| EP-1605936-A1 | ARYL SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS | Merck & Co. Inc. (US) | 2005-12-21 | — | — | EP | claimed |
| WO-2004082678-A1 | ARYL SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS | MERCK & CO. INC. (US) | 2004-09-30 | — | — | WO | claimed |
| WO-2004082602-A2 | CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS | MERCK & CO. INC. (US) | 2004-09-30 | — | — | WO | claimed |
| US-6498257-B1 | 2,3-olefinic epothilone derivatives | BRISTOL-MYERS SQUIBB COMPANY | 2002-12-24 | — | — | US | claimed |